Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs735665
rs735665
GRAMD1B
0.840 GeneticVariation BEFREE The haplotype tagged by rs35923643-G (or its proxy SNP rs735665-A) is also known as the top risk allele for chronic lymphocytic leukemia (CLL), and a main increasing allele for general IgM. 29547969

2018
dbSNP: rs735665
rs735665
GRAMD1B
A 0.840 GeneticVariation GWASCAT A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia. 24292274

2014
dbSNP: rs735665
rs735665
GRAMD1B
A 0.840 GeneticVariation GWASDB A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia. 24292274

2014
dbSNP: rs735665
rs735665
GRAMD1B
A 0.840 GeneticVariation GWASCAT Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. 23770605

2013
dbSNP: rs735665
rs735665
GRAMD1B
A 0.840 GeneticVariation GWASDB Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. 23770605

2013
dbSNP: rs735665
rs735665
GRAMD1B
A 0.840 GeneticVariation GWASDB Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. 22700719

2012
dbSNP: rs735665
rs735665
GRAMD1B
A 0.840 GeneticVariation GWASCAT Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. 22700719

2012
dbSNP: rs735665
rs735665
GRAMD1B
0.840 GeneticVariation BEFREE Common single nucleotide polymorphisms (SNPs) at 2q13 (rs17483466), 2q37.1 (rs13397985), 2q37.3 (rs757978), 6p25.3 (rs872071), 8q24.21 (rs2456449), 11q24.1 (rs735665), 15q21.3 (rs7169431), 15q23 (rs7176508), 16q24.1 (rs305061), and 19q13.32 (rs11083846) have been shown to confer a modest but significant increase in CLL risk. 20855867

2010
dbSNP: rs735665
rs735665
GRAMD1B
0.840 GeneticVariation BEFREE Combined data provided statistically significant support for an association between genotypes at rs13397985, rs872071, rs735665, rs7176508 and rs11083846 and CLL risk. 20553269

2010
dbSNP: rs735665
rs735665
GRAMD1B
A 0.840 GeneticVariation GWASCAT We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)). 18758461

2008
dbSNP: rs735665
rs735665
GRAMD1B
0.840 GeneticVariation BEFREE We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)). 18758461

2008
dbSNP: rs735665
rs735665
GRAMD1B
A 0.840 GeneticVariation GWASDB We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)). 18758461

2008